News

October 15, 2018October 15, 2018

Neurological Dysfunction Detectable Before Huntington’s Diagnosis, Study Finds

News

Signs of neurological dysfunction can start long before a clinical diagnosis of Huntington’s disease, a study shows. Early cognitive rehabilitation programs might be useful in the pre-manifest stage of the disease. The study, ... Read more

October 11, 2018October 11, 2018

New Blood Test May Track Early Changes in Huntington’s Disease, Study Finds

News

Two proteins present in the blood and brains of patients with Huntington’s disease may be used as biomarkers to detect the earliest changes caused by the disease, according to ... Read more

October 9, 2018October 9, 2018

Advocacy Groups, Doctors Question Rising Prices of Rare Disease Treatments

News

Half a year has gone by since disgraced pharma executive Martin Shkreli was sentenced to seven years in federal prison for securities and wire fraud while heading San Diego-based ... Read more

October 9, 2018October 9, 2018

Northwestern University Receives $12.6 Million to Study Protein Balance Mechanisms in Health and Disease

News

The National Institute on Aging at the National Institutes of Health (NIH) has granted $12.6 million to Northwestern University to study the role of protein quality control mechanisms in ... Read more

October 4, 2018October 4, 2018

Mutant Huntingtin and Neurofilament Light Protein Could be Biomarkers in Huntington’s, Study Suggests

News

Measuring concentrations of mutant huntingtin (mHTT) protein and another protein, called neurofilament light protein (NfL), can provide early and specific indications of Huntington’s-related changes, according to a new study. ... Read more

October 2, 2018October 2, 2018

Phase 1b Trial Will Test Nilotinib’s Safety, Tolerability in Huntington’s Patients

News

A Georgetown University Medical Center (GUMC) Phase 1b clinical trial is recruiting patients to test the safety and tolerability of a leukemia treatment called nilotinib in Huntington’s disease patients. ... Read more

September 27, 2018September 27, 2018

UTHealth, Astros Team Up to Give Huntington’s Patients a Day at the Ballpark

News

With the support of Houston Astros pitcher Joe Smith and the University of Texas Health Science Center at Houston (UTHealth), about 100 Huntington’s disease patients and their families got ... Read more

September 24, 2018September 24, 2018

Roche Set to Start 2 Clinical Studies of Potential Huntington’s Therapy RG6042

News

Two new clinical studies of Roche’s investigational therapy RG6042 for Huntington’s disease (HD) are planned to start by the end of 2018 and will begin enrolling participants by early 2019. These ... Read more

September 21, 2018September 21, 2018

#NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington

News

More than 700 medical experts, pharmaceutical executives, patient advocates, and others are expected to converge on Washington, D.C., next month for the 2018 NORD Rare Diseases & Orphan Products ... Read more

September 19, 2018September 19, 2018

Metformin Reversed Symptoms Associated with Huntington’s Disease in Mouse Study

News

Researchers narrowing in on early neuronal functioning stages of development, well before Huntington’s disease symptoms appear, believe they have found a potentially important path to intervening with the diabetes medication metformin. Their ... Read more

Pin It on Pinterest